Bioventix (LON:BVXP) Reaches New 52-Week Low – Should You Sell?

Bioventix PLC (LON:BVXPGet Free Report)’s stock price hit a new 52-week low during trading on Tuesday . The stock traded as low as GBX 2,552 ($32.86) and last traded at GBX 2,603.90 ($33.53), with a volume of 13413 shares traded. The stock had previously closed at GBX 2,590 ($33.35).

Bioventix Price Performance

The business’s 50-day simple moving average is GBX 2,926.94 and its two-hundred day simple moving average is GBX 3,387.37. The stock has a market capitalization of £143.79 million, a price-to-earnings ratio of 17.76 and a beta of 0.35.

Bioventix Company Profile

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.

Read More

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.